Clinical Trial: Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF

U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07082842) titled 'Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF' on July 02.

Brief Summary: A multicenter, parallel, randomized, placebo (double-blind) and pirfenidone (open-label) controlled Phase III clinical trial to evaluate the efficacy and safety of HEC585 in patients with idiopathic pulmonary fibrosis (IPF)

Study Start Date: Oct. 09, 2025

Study Type: INTERVENTIONAL

Condition: Idiopathic Pulmonary Fibrosis (IPF)

Intervention: DRUG: HEC585

HEC585 tablet, taken once daily

DRUG: Placebo

HEC585 Simulation Board, taken once daily

DRUG: Pirfenidone

Pirfenidone, taken three times a day

Recruitment Status: NOT_YET_RECRU...